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Serotonin type 7 receptors (5-HT7) are expressed in several brain areas, regulate brain
development, synaptic transmission and plasticity, and therefore are involved in various
brain functions such as learning and memory. A number of studies suggest that
5-HT7 receptors could be potential pharmacotherapeutic target for cognitive disorders.
Several abnormalities of serotonergic system have been described in patients with
autism spectrum disorder (ASD), including abnormal activity of 5-HT transporter, altered
blood and brain 5-HT levels, reduced 5-HT synthesis and altered expression of 5-HT
receptors in the brain. A specific role for 5-HT7 receptors in ASD has not yet been
demonstrated but some evidence implicates their possible involvement. We have recently
shown that 5-HT7 receptor activation rescues hippocampal synaptic plasticity in a mouse
model of Fragile X Syndrome, a monogenic cause of autism. Several other studies have
shown that 5-HT7 receptors modulate behavioral flexibility, exploratory behavior, mood
disorders and epilepsy, which include core and co-morbid symptoms of ASD. These
findings further suggest an involvement of 5-HT7 receptors in ASD. Here, we review the
physiological roles of 5-HT7 receptors and their implications in Fragile X Syndrome and
other ASD.
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INTRODUCTION
The monoamine serotonin (5-HT) is widely distributed in the
central nervous system (CNS), where it functions as neurotrans-
mitter and neuro-hormone to control mood, circadian rhythm,
nociception, hormone secretion, feeding and sexual behavior
(Hannon and Hoyer, 2008; Nichols and Nichols, 2008). 5-HT
and its receptors are also present in peripheral tissues where they
influence several functions including intestinal motility (Foxx-
Orenstein et al., 1996), immune/inflammatory response (Ahern,
2011), modulation of nociception (Cervantes-Duran et al., 2013).
Seven families of 5-HT receptors have been identified to date
in mammals, 5-HT1 through 5-HT7, each including distinct
receptor subtypes. 5-HT3 receptors are ligand-gated ion channels
mediating fast depolarization (Sugita et al., 1992). All the other
5-HT receptors are G protein-coupled metabotropic receptors: 5-
HT1 and 5-HT5 receptors inhibit adenylate cyclase, 5-HT4, 5-HT6
and 5-HT7 receptors instead stimulate adenylate cyclase, whereas
the 5-HT2 receptor family is positively linked to phospholipase
C (Hannon and Hoyer, 2008; Millan et al., 2008; Pytliak et al.,
2011).
5-HT7 receptors were the last to be cloned in 1993 by
different independent laboratories (Lovenberg et al., 1993;
Monsma et al., 1993; Ruat et al., 1993) and their role was
initially poorly understood. In the last decade, evidence has
emerged that 5-HT7 receptors play an important role in
the control of body temperature, sleep/wake cycle, nocicep-
tion, learning and memory (Table 1). 5-HT7 receptors are
also involved in mood disorders, epilepsy and pain and are
starting to be considered as possible targets for these disor-
ders.
The structural, pharmacological and functional features of 5-
HT7 receptors have been extensively illustrated in recent reviews
(Matthys et al., 2011; Gellynck et al., 2013); thus, we will only
briefly outline these receptor properties in the first part of the
present work. A core part of our review is dedicated to the
physiological functions regulated by 5-HT7 receptors and par-
ticularly to 5-HT7 receptor-mediated effects on cognition and
mood regulation, two higher brain functions that are strictly
related and mutually influence each other. Higher brain func-
tions depend on the activity of brain neuronal networks, which
are profoundly affected by changes in neuronal excitability and
synaptic efficacy. For this reason, we will describe the effects
of 5-HT7 receptor activation on intrinsic neuronal excitability,
synaptic transmission and synaptic plasticity, and will discuss
the possible functional consequences of these 5-HT7 receptor-
mediated effects.
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Table 1 | In vivo effects of pharmacological activation, pharmacological blockade or genetic ablation of 5-HT7 receptors.
In vivo effects of 5-HT7 receptor manipulation References
Learning Genetic ablation of 5-HT7 receptors: impairment of fear-related learning and
object location memory
Roberts et al. (2004a) and Sarkisyan and
Hedlund (2009)
Pharmacological activation of 5-HT7 receptors:
– improvement of contextual learning Eriksson et al. (2008, 2012)
– improvement of instrumental learning Perez-Garcia and Meneses (2005)
– improvement of novelty detection Freret et al. (2014)
Pharmacological blockade of 5-HT7 receptors: impairment of novelty
detection
Ballaz et al. (2007a)
Pharmacological blockade of 5-HT7 receptors: improvement of long-term
memory
Gasbarri et al. (2008)
Behavioral flexibility Pharmacological blockade of 5-HT7 receptors: improved behavioral flexibility Nikiforuk (2012) and Nikiforuk and Popik (2013)
Exploratory activity Pharmacological activation of 5-HT7 receptors:
– reduced ambulatory activity Clissold et al. (2013)
– enhanced ambulatory activity Adriani et al. (2012) and Ruocco et al. (2013)
Sleep/wake cycle Genetic ablation of 5-HT7 receptors: reduced REM sleep Hedlund et al. (2005)
Pharmacological blockade of 5-HT7 receptors: reduced REM sleep Hagan et al. (2000), Thomas et al. (2003),
Bonaventure et al. (2007) and Monti et al. (2012)
Pharmacological activation of 5-HT7 receptors:
– reduced REM sleep Monti et al. (2008, 2014)
– phase-advance shift of circadian rhythm Adriani et al. (2012)
Thermoregulation Pharmacological activation of 5-HT7 receptors: hypothermia Hagan et al. (2000), Guscott et al. (2003) and
Hedlund et al. (2003, 2010)
Nociception Pharmacological activation of 5-HT7 receptors: central antinociceptive and
peripheral pro-nociceptive effects
Yanarates et al. (2010) and Viguier et al. (2012,
2013)
Mood Genetic ablation of 5-HT7 receptors: antidepressant effects Hedlund et al. (2005) and Guscott et al. (2005)
Pharmacological blockade of 5-HT7 receptors: antidepressant effects Hedlund et al. (2005), Wesolowska et al.
(2006a) and Mnie-Filali et al. (2011)
Non-selective 5-HT7 receptor antagonists (atypical antipsychotics) behave as
antidepressant in humans
Abbas et al. (2009), Guilloux et al. (2013) and
Woo et al. (2013)
Genetic ablation of 5-HT7 receptors: no alteration of anxiety Roberts et al. (2004a) and Guscott et al. (2005)
Pharmacological blockade of 5-HT7 receptors: anxiolytic effects Wesolowska et al. (2006a,b)
Epilepsy Pharmacological blockade of 5-HT7 receptors: antiepileptic effects against:
– audiogenic seizures Bourson et al. (1997)
– absence epilepsy Graf et al. (2004)
– pilocarpine-induced seizures Yang et al. (2012)
Pharmacological activation of 5-HT7 receptors: antiepileptic effect against
picrotoxin-induced seizures
Pericic and Svob Strac (2007)
Genetic ablation of 5-HT7 receptors: reduced sensitivity to electrically- and
chemically-induced seizures
Witkin et al. (2007)
In the last part, we will review the current literature showing
an impairment of the brain serotonin system in autism spectrum
disorders (ASD) and its involvement in their pathophysiology.
A possible malfunction of 5-HT7 receptors in ASD has not
yet been investigated. In this respect, we will highlight a num-
ber of reports indicating that 5-HT7 receptors regulate many
physiological functions that are altered in ASD. In addition,
we will provide indication from different research groups and
from our laboratories that pharmacological manipulation of 5-
HT7 receptors might be considered as a therapeutic strategy in
ASD.
CHARACTERIZATION OF 5-HT7 RECEPTORS
LOCALIZATION, STRUCTURE AND PHARMACOLOGICAL PROFILE
5-HT7 receptors are highly expressed in the thalamus, hypotha-
lamus and hippocampus of mice and rats; significant amounts
were detected in cerebral cortex, amygdala, striatum, cerebellum
and spinal cord (Belenky and Pickard, 2001; Neumaier et al.,
2001; Bickmeyer et al., 2002; Geurts et al., 2002; Muneoka and
Takigawa, 2003; Doly et al., 2005; reviewed by Hedlund and
Sutcliffe, 2004).
In the human brain, 5-HT7 receptor mRNA was detected
in many CNS areas, with highest expression levels in thalamus,
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hypothalamus, amygdala and hippocampus (Hagan et al., 2000).
Autoradiographic studies confirmed that 5-HT7 receptor levels
in human brain are in good correlation with those found in
rodents, with high density in thalamus, dorsal raphe, hippocam-
pus (Martin-Cora and Pazos, 2004; Varnäs et al., 2004) and
hypothalamus (Varnäs et al., 2004). Unlike in rodents, in the
human brain 5-HT7 receptor binding sites were also found at high
levels in caudate nucleus, putamen and substantia nigra (Martin-
Cora and Pazos, 2004).
In the rodent brain, the immunoreactivity for 5-HT7 receptors
was high in several regions at birth and then decreased progres-
sively during postnatal development (Muneoka and Takigawa,
2003; García-Alcocer et al., 2006; Kobe et al., 2012). However,
in spite of the reported age-related reduction in their brain
expression levels, 5-HT7 receptors exert important functions also
in the adult (see Section Physiological Functions Regulated by
5-HT7 Receptors). This conclusion is supported by several data:
first of all, 5-HT7 receptors have been detected in the brain of
adult animals (Neumaier et al., 2001; Geurts et al., 2002; Muneoka
and Takigawa, 2003). In the human brain, the presence of 5-
HT7 receptors was confirmed by post-mortem studies on adult
subjects (age range 22–73 years; Martin-Cora and Pazos, 2004;
Varnäs et al., 2004). Moreover, systemic administration of 5-
HT7 receptor agonists affected body temperature (Naumenko
et al., 2011) and circadian rhythms (Adriani et al., 2012; Monti
et al., 2014; Romano et al., 2014) in adult animals and improved
learning in young adults (Eriksson et al., 2008; Freret et al., 2014).
All these data indicate that 5-HT7 receptor-mediated effects are
still present at adult age and exert an important control on various
physiological functions.
5-HT7 receptors display the typical structure of G protein-
coupled receptors (GPCRs) with seven transmembrane domains
and were initially characterized for their ability to stimulate
adenylate cyclase (Bard et al., 1993; Lovenberg et al., 1993; Ruat
et al., 1993; Shen et al., 1993).
Among all 5-HT receptor subtypes, 5-HT7 receptors display
the highest affinity (in the low nanomolar range) for the natural
agonist serotonin (Ruat et al., 1993). Other high affinity agonists
for 5-HT7 receptors are 5-carboxamidotryptamine (5-CT) and
8-hydroxy-N,N-dipropyl-aminotetralin (8-OH-DPAT), both also
showing high affinity for 5-HT1A receptors (Bard et al., 1993;
Lovenberg et al., 1993; Ruat et al., 1993). Selective agonists for 5-
HT7 receptors were lacking until recently (Di Pilato et al., 2014).
The first compound described as a 5-HT7 receptor agonist was
AS-19, a partial agonist with high affinity but moderate selectivity
for 5-HT7 receptors (Brenchat et al., 2009). The most selective 5-
HT7 receptor agonists described to date are the compounds E-
55888 and E-57431 (not commercially available), produced by
Esteve pharmaceutical company (Brenchat et al., 2009, 2012).
Another high-affinity and selective 5-HT7 receptor agonist is LP-
211 (indicated as compound 25 in the first publication Leopoldo
et al., 2008), that shows excellent brain permeation properties
(Hedlund et al., 2010). In vivo administration of LP-211 induced
hypothermia in wild-type but not in 5-HT7 KO mice (Hedlund
et al., 2010) and shifted the sleep-wake cycle (Adriani et al., 2012),
two typical 5-HT7 receptor-mediated effects. Other analogs of
LP-211 with improved selectivity and pharmacokinetic properties
have been synthesized (Leopoldo, personal communication) and
are currently under investigation in our laboratories as possible
novel 5-HT7 receptor agonists.
Concerning antagonists, several antidepressant and antipsy-
chotic drugs showed high affinity for 5-HT7 receptors and
behaved as antagonists on a cyclic adenosine monophosphate
(cAMP) formation assay (Shen et al., 1993; Roth et al., 1994; see
Section Mood Disorders). Selective and high-affinity antagonists
of 5-HT7 receptors are also available, among which the compound
SB-269970 is to date considered the most reliable (Hagan et al.,
2000; Guscott et al., 2003; Hedlund et al., 2003).
COUPLING TO INTRACELLULAR TRANSDUCTION MECHANISMS
5-HT7 receptors display interesting transduction properties,
being able to couple to Gs and G12 GTP-binding proteins, which
activate divergent signaling pathways (reviewed by Woehler and
Ponimaskin, 2009; Matthys et al., 2011; Gellynck et al., 2013).
Since their discovery, 5-HT7 receptors were found to be cou-
pled to Gs and induce adenylate cyclase activation, cAMP forma-
tion and activation of protein kinase A (PKA; Bard et al., 1993;
Lovenberg et al., 1993; Ruat et al., 1993).
Downstream to cAMP formation, 5-HT7 receptors can acti-
vate the extracellular signal-regulated kinase (ERK), as shown
in transfected cells expressing 5-HT7 receptors (Lin et al., 2003;
Norum et al., 2003) and in native rat hippocampal neurons
(Errico et al., 2001; Lin et al., 2003). 5-HT7 receptor-induced
activation of ERK was mediated either by PKA (Norum et al.,
2003) or by a cAMP-dependent, PKA-independent pathway
involving exchange proteins directly activated by cAMP (Epacs)
(Lin et al., 2003). In line with this result, cAMP-dependent but
PKA-independent 5-HT7 receptor-mediated effects have been
described (Chapin and Andrade, 2001; Bonsi et al., 2007).
5-HT7 receptors can activate additional intracellular biochem-
ical cascades, among which the kinase Akt (also known as protein
kinase B; Hoffman and Mitchell, 2011; Johnson-Farley et al.,
2005).
As mentioned above, 5-HT7 receptors can also couple to G12
(Kvachnina et al., 2005), a heterotrimeric G protein that mod-
ulates the activity of “small” monomeric GTPases (Hall, 1998),
such as members of the Rho family Rho, Rac and Cdc42. Through
the G12-dependent activation of RhoA and Cdc42 5-HT7 receptor
activation regulates gene transcription and neuronal morphology
(Kvachnina et al., 2005).
The mechanisms regulating 5-HT7 receptor coupling to Gs
or G12 are not clear. Recent evidence suggests that agonist-
induced dynamic palmitoylation of 5-HT7 receptors affects its
Gs-mediated constitutive activity with no effect on G12-mediated
activity (Kvachnina et al., 2009; Gorinski and Ponimaskin, 2013).
This result implies that pathways inducing palmitoylation of
5-HT7 receptors might modify their constitutive activity and
switch their intracellular coupling, ultimately changing their final
effect.
Another interesting finding is that the expression of Gs remains
constant during development, whereas the expression level of
G12 is higher at early post natal age and parallels the expression
level of 5-HT7 receptors; consistently, 5-HT7 receptor-mediated
effects on synapse formation and function were observed in the
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hippocampus of juvenile but not adult mice, indicating a crucial
role of the 5-HT7/G12 pathway in the development of brain
synaptic circuitry (Kobe et al., 2012).
A particular feature of 5-HT7 receptors, similar to other
GPCRs, is the ability to form receptor complexes, either homo- or
heterodimers, in which monomers reciprocally modulate receptor
trafficking, ligand binding affinity and coupling to intracellular
signaling cascades (Renner et al., 2012; Teitler and Klein, 2012).
For example, it has been suggested that a 5-HT1A/5-HT7 het-
erodimer interaction plays a modulatory role in the control of
body temperature (Matthys et al., 2011). This is a further element
of complexity in 5-HT receptor-mediated signal transduction
mechanisms.
5-HT7 RECEPTORS REGULATE SYNAPSE DEVELOPMENT
5-HT plays a crucial role in shaping brain structure and cir-
cuits during development through modulation of neural cell
proliferation, migration and differentiation, as well as neurite
outgrowth, axonal guidance and synaptogenesis (Gaspar et al.,
2003). Accordingly, early changes in 5-HT brain levels during
development affect the functional organization of brain networks
and may underlie the pathogenesis of neurodevelopmental dis-
orders including autism (reviewed by Lesch and Waider, 2012).
While the role of some 5-HT receptors during brain develop-
ment has been ascertained (Sodhi and Sanders-Bush, 2004), the
involvement of 5-HT7 receptors has only recently emerged. As
mentioned above, the group of Ponimaskin demonstrated that
in mouse hippocampal neurons 5-HT7 receptor activation stimu-
lated the small GTP-ases RhoA and Cdc42 and enhanced neurite
elongation, dendritic spine density, the number of synaptic con-
tacts and the amount of AMPA receptors expressed at synapses,
leading to increased synaptic efficacy (Kvachnina et al., 2005; Kobe
et al., 2012). In line with these results, it was recently shown that
the 5-HT7 receptor agonists 8-OH-DPAT and LP-211 stimulated
neurite outgrowth in primary cultures of mouse and rat striatal
and cortical neurons by activation of the cyclin-dependent protein
kinase 5 (Cdk5), a kinase playing an important role in micro-
tubule assembly and cytoarchitecture rearrangements (Speranza
et al., 2013).
MODULATION OF NEURONAL EXCITABILITY BY 5-HT7
RECEPTORS
5-HT7 RECEPTOR ACTIVATION EXERTS DEPOLARIZING EFFECTS
Brain 5-HT7 receptors modulate neuronal networks by playing
a crucial role in brain wiring during development. However,
as mentioned before, 5-HT7 receptor-mediated effects are not
restricted to a defined developmental window, as a large number
of studies show that 5-HT7 receptors modulate neuronal excitabil-
ity, synaptic transmission and synaptic plasticity both during
development and adult life. 5-HT7 receptors control neuronal
intrinsic excitability by modulating non-synaptic membrane ion
currents which directly affect neuronal firing. 5-HT7 receptor
agonists exerted slow depolarizing effects and increased neu-
ronal firing in several brain areas (Figure 1), among which the
anterodorsal nucleus of the rat thalamus (Chapin and Andrade,
2001), rat globus pallidus (Chen et al., 2008), mouse hippocampal
CA1 region (Bickmeyer et al., 2002) and mouse trigeminal
nucleus caudalis (Yang et al., 2014). Activation of 5-HT7 recep-
tors enhanced the firing rate of rat CA1 pyramidal neurons
(Tokarski et al., 2003), CA3 pyramidal neurons (Gill et al., 2002),
striatal cholinergic interneurons (Bonsi et al., 2007), prefrontal
cortex pyramidal neurons (Zhang, 2003; Béïque et al., 2004a)
and nucleus accumbens (NAc) neurons (Ishihara et al., 2013).
In a spinal cord slice preparation, 5-HT application induced a
locomotor-like rhythmic firing activity of motoneurons in wild
type but not in 5-HT7 KO mice, indicating that the excitability of
spinal motoneurons was enhanced by 5-HT7 receptors (Liu et al.,
2009).
In many of the studies above cited, 5-HT7 receptor-induced
depolarization was mediated by inhibition of a post-spike AHP or
by enhancement of a hyperpolarization-activated inward cation
current (Ih).
5-HT7 RECEPTOR ACTIVATION INHIBITS POST-SPIKE
AFTERHYPERPOLARIZATION (AHP)
Action potentials are followed by a negative shift in mem-
brane potential named afterhyperpolarization (AHP), which is
mediated by a Ca2+-dependent K+ current triggered by Ca2+
influx. The subsequent efflux of K+ ions hyperpolarizes the
membrane during a few seconds reducing neuronal firing rate,
a phenomenon called “spike frequency adaptation” (Sah, 1996).
Activation of 5-HT7 receptors inhibited a slow AHP (sAHP) in
thalamic neurons (Goaillard and Vincent, 2002), in CA3 pyrami-
dal neurons (Bacon and Beck, 2000; Gill et al., 2002) and in CA1
pyramidal neurons (Tokarski et al., 2003; Figure 1). Likewise, in
rat trigeminal motoneurones 5-HT7 receptor activation reduced a
Ca2+-dependent K+ current responsible for a medium-duration
afterhyperpolarization (mAHP), another type of AHP with a
time-course faster than the sAHP and with similar inhibitory
effects on neuronal excitability (Inoue et al., 2002). Modulation
of the AHP by 5-HT7 receptors was mediated by activation of the
cAMP/PKA pathway (Goaillard and Vincent, 2002; Inoue et al.,
2002).
Modulation of the AHP has profound effects on neuronal
firing. By inhibiting post-spike mAHP and sAHP, 5-HT7 recep-
tor activation enhances neuronal firing rate and reduces spike
frequency adaptation. In addition, 5-HT7 receptor-mediated
modulation of sAHP is likely to involve broader functional con-
sequences, as intrinsic excitability and synaptic inputs mutually
influence each other. In fact, Ca2+ influx through N-methyl-D-
aspartate (NMDA) channels can also activate the sAHP (Lancaster
et al., 2001), which implies that synaptic activation also modulates
the AHP. Changes in AHP amplitude have been observed follow-
ing activation of NMDA and kainate receptors (Cherubini et al.,
1990) and group I metabotropic glutamate receptors (mGluRs;
Ireland and Abraham, 2002).
The AHP in turn reduces NMDA-mediated synaptic trans-
mission: it has been proposed that activation of AHP, by
hyperpolarizing the membrane, would favor Mg2+ blockade
of NMDA channels and reduce NMDA-mediated transmis-
sion and plasticity (Wu et al., 2004; Fernández de Sevilla
et al., 2007). Vice-versa, conditions reducing the AHP lead
to depolarization and removal of Mg2+ blockade, thus are
likely to enhance NMDA-mediated long term plasticity and
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FIGURE 1 | Effects of 5-HT7 receptor activation on neuronal
excitability, synaptic transmission and synaptic plasticity in the
rodent brain. Activation of 5-HT7 receptors induced depolarization in
several brain regions; in many cases, depolarization was mediated by
inhibition of a post-spike afterhyperpolarization (AHP) and/or
enhancement of a hyperpolatization-activated cation current (Ih; see
explanations in the text). Activation of 5-HT7 receptors modulated
glutamate-mediated synaptic transmission and plasticity in frontal cortex
and hippocampus. 5-HT7 receptors differently modulated GABAergic
synaptic transmission in distinct brain areas; notably, activation of 5-HT7
receptors in raphe nuclei inhibited GABAergic interneurons, enhancing
the activity of serotonergic raphe neurons and 5-HT release in target
structures. Most of the results illustrated here were obtained in the rat,
with the following exceptions: mouse (Bickmeyer et al., 2002; Costa
et al., 2012a; Yang et al., 2014), hamster (Glass et al., 2003) and guinea
pig (Roberts et al., 2004b).
learning. Consistent with this hypothesis, it was shown that
the amplitude of AHP in hippocampal neurons was decreased
after learning (Disterhoft et al., 1996; Moyer et al., 1996; Oh
et al., 2009) and age-related learning deficits are accompanied
by increased AHP (Disterhoft et al., 1996; Tombaugh et al.,
2005).
Since 5-HT7 receptor activation is able to inhibit post-spike
AHP in many brain regions, as described above, the sub-
sequent depolarization might favor NMDA receptor-mediated
synaptic plasticity and ultimately enhance learning. As a mat-
ter of fact, several studies indicate that 5-HT7 receptor acti-
vation exerts pro-cognitive effects (see Section Learning and
Memory).
5-HT7 RECEPTOR ACTIVATION ENHANCES A
HYPERPOLARIZATION-ACTIVATED CATION CURRENT (Ih)
Another non-synaptic ion current modulated by 5-HT7 receptors
is a hyperpolarization-activated cation current (Ih). Ih is carried
by Na+ and K+ ions and is activated by hyperpolarization beyond
−60 mV, thus is already active at resting membrane potential.
The voltage-dependence of Ih activation is modulated by cAMP,
with increases in cAMP levels facilitating Ih activation (Chen
et al., 2001). The physiological consequences of Ih activation are
very complex, as it differently affects membrane excitability and
synaptic responsiveness. Concerning membrane excitability, Ih
shifts the value of resting membrane potential towards depo-
larization. With respect to synaptic responsiveness, Ih instead
exerts a membrane-shunting effect that reduces the amplitude
and duration of excitatory post-synaptic potentials. Thus, an
enhancement of Ih, although producing a depolarizing shift in
membrane potential, ultimately decreases synaptic responsive-
ness, as it reduces neuronal ability to elicit action potentials
in response to synaptic inputs. Ih also reduces the temporal
summation of synaptic signals. Notably, the channels respon-
sible for Ih (hyperpolarization-activated cyclic nucleotide-gated
non-specific cation channels, HCN) are maximally expressed in
distal dendrites, where integration of synaptic signals mostly
occurs (Magee, 1998, 1999); reviewed by Mozzachiodi and Byrne
(2010).
It was shown that 5-HT7 receptor activation enhanced Ih in
dorsal root ganglion neurons (Cardenas et al., 1999), in mouse
hippocampus (Bickmeyer et al., 2002), in the anterodorsal tha-
lamic nucleus (Chapin and Andrade, 2001) and in rat globus
pallidus (Bengtson et al., 2004; Chen et al., 2008; Figure 1). In
most cases, 5-HT7 receptor-mediated enhancement of Ih was
mediated by an increase in cAMP levels (Cardenas et al., 1999;
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Chapin and Andrade, 2001; Bickmeyer et al., 2002; Bengtson et al.,
2004).
Neurotransmitter-mediated modulation of Ih has impor-
tant functional consequences on neuronal rhythmic firing
(McCormick and Pape, 1990). Ih is also suggested to be involved
in epilepsy, since either an increase (Surges et al., 2012) or a
decrease (Jung et al., 2007, 2011) of Ih have been reported in
different types of epilepsy.
Changes in Ih also occur during long-term synaptic plasticity
(reviewed by Mozzachiodi and Byrne, 2010). Ih was increased
during NMDA-mediated long term potentiation (LTP; Fan et al.,
2005) and decreased after the induction of metabotropic glu-
tamate receptor-mediated long term depression (mGluR-LTD;
Brager and Johnston, 2007). Interestingly, it was recently shown
that hippocampal Ih is altered in Fmr1KO mice, the mouse model
of Fragile X syndrome, in which mGluR-mediated signaling is
deregulated. In Fmr1 KO mice, Ih is abnormally enhanced in the
apical dendrites but not in the soma of CA1 pyramidal neurons
and NMDA-mediated modulation of Ih is disrupted (Brager
et al., 2012; Brager and Johnston, 2014). The authors suggested
that the subsequent reduction in dendritic synaptic integration
together with enhanced intrinsic excitability may participate to
epilepsy, a typical feature of Fmr1KO mice as well as of Fragile X
patients.
In summary, modulation of Ih by 5-HT7 receptors is likely
to have important consequences on neuronal firing and synaptic
responsiveness and might account for the effects exerted by 5-HT7
receptor activation on synaptic transmission and on epilepsy (see
below).
MODULATORY ROLE OF 5-HT7 RECEPTORS ON SYNAPTIC
TRANSMISSION AND PLASTICITY
EFFECTS OF 5-HT7 RECEPTOR ACTIVATION ON GABAERGIC SYNAPTIC
TRANSMISSION
5-HT7 receptors differently modulate the activity of GABAer-
gic inhibitory interneurons in distinct brain areas (Figure 1).
An early study showed that 5-HT7 receptor activation reduced
GABAA receptor-activated current in cultured rat SCN neu-
rons acting through a post-synaptic cAMP-mediated mecha-
nism (Kawahara et al., 1994). Also in raphe nuclei 5-HT7
receptor activation reduced GABAergic transmission. In raphe
nuclei, GABAergic interneurons exert a negative control on
the activity of serotonergic neurons, inhibiting 5-HT release
from raphe efferent fibers. When a 5-HT7 receptor antag-
onist was applied in raphe nuclei, 5-HT efflux onto tar-
get structures was reduced (Glass et al., 2003; Roberts
et al., 2004b). Thus, activation of 5-HT7 receptors in raphe
nuclei reduces GABA-mediated inhibition of raphe serotoner-
gic neurons and consequently enhances 5-HT release in target
structures.
In the hippocampus, 5-HT7 receptor activation was instead
shown to stimulate the activity of GABAergic interneurons. Appli-
cation of a 5-HT7 receptor agonist enhanced the frequency of
GABA-mediated spontaneous inhibitory post-synaptic currents
(sIPSCs) recorded from rat CA1 pyramidal neurons, indicat-
ing an increased GABA release from interneurons (Tokarski
et al., 2011). The authors suggest that 5-HT7 receptors exerted
two effects, both at a pre-synaptic level: an enhancement of
glutamate release from fibers targeting GABAergic interneurons
and an increase of GABA release from interneuron terminals.
In the CA1 region, GABAergic interneurons represent a system
of feed-forward and feedback inhibition of pyramidal neurons,
being activated by afferent fibers (among which the raphe-
hippocampal serotonergic pathway), by Schaffer collaterals as
well as by recurrent collaterals from pyramidal neurons (Freund
and Buzsaki, 1996). Therefore, 5-HT7 receptors exert a very
complex modulation of hippocampal circuits, as they directly
depolarize pyramidal neurons (Tokarski et al., 2003) and simulta-
neously regulate their firing by enhancing GABAergic inhibitory
control.
5-HT7 receptor activation enhanced GABAergic transmission
also in rat globus pallidus (Chen et al., 2008). To summarize, in
the hippocampus and globus pallidus 5-HT7 receptor activation
stimulates GABA release from interneurons, differing from results
observed in suprachiasmatic nucleus (SCN) and dorsal raphe,
where 5-HT7 receptor activation instead reduces GABAergic
transmission.
EFFECTS OF 5-HT7 RECEPTOR ACTIVATION ON GLUTAMATE-MEDIATED
SYNAPTIC TRANSMISSION AND PLASTICITY
Two different reports indicate that 5-HT7 receptor activation
can stimulate glutamate release from glutamatergic terminals.
In rat frontal cortex, glutamate-mediated synaptic transmission
was enhanced by activation of 5-HT7 receptors (Béïque et al.,
2004b) and decreased by the 5-HT7 receptor antagonist SB-
269970 (Tokarski et al., 2012a; Figure 1). In both studies, 5-HT7
receptor-mediated effect was exerted at a pre-synaptic level on
glutamatergic terminals.
In the hippocampus, 5-HT7 receptors modulate glutamate-
mediated transmission acting at a post-synaptic level. Field
recordings of excitatory post-synaptic potentials (EPSPs) from
rat hippocampal slices have shown that serotonin inhibits the
perforant path input to the CA1 region, an effect partially
mediated by 5-HT7 receptors and exerted at a post-synaptic
level (Otmakhova et al., 2005). The authors suggest that 5-
HT7 receptor-mediated reduction of EPSP amplitude might be
due to an enhancement of the hyperpolarization-activated cur-
rent Ih, similar to what observed in several brain regions (see
above).
The other main input to CA1 pyramidal neurons is
represented by Schaffer collaterals from CA3 pyramidal neu-
rons. We have studied the effects of serotonin on gluta-
matergic transmission in the CA3-CA1 synapse in mouse and
rat hippocampal slices and showed that activation of post-
synaptic 5-HT7 receptors enhances the amplitude of the AMPA
receptor-mediated component of the excitatory post synaptic
current (EPSCAMPA), which is responsible for basal glutamater-
gic transmission (Costa et al., 2012b). In the same study, we
observed instead that 5-HT1A receptors inhibit AMPA-mediated
CA3-CA1 synaptic transmission. These data provide a physiolog-
ical substrate to the previous observation that 5-HT7 receptor
activation exerts a pro-cognitive action and is able to counter-
act 5-HT1A-mediated impairment of learning (Eriksson et al.,
2008).
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In the last few years, evidence has emerged that 5-HT7 recep-
tors can also modulate long-term synaptic plasticity (Figure 1).
As already mentioned, in mice hippocampal neurons activation
of 5-HT7 receptors enhanced basal synaptic transmission by
increasing the number of AMPA receptors at synapses but
also modulates glutamate-mediated long-term synaptic plasticity,
reducing the amount of LTP in the CA3-CA1 synapse (Kobe
et al., 2012). The authors suggested that 5-HT7 receptor-mediated
enhancement of basal glutamatergic transmission might have
prevented further potentiation, thus reducing LTP (Kobe et al.,
2012). In contrast with this report, mice lacking 5-HT7 recep-
tors (5-HT7 KO) display decreased LTP in the CA3-CA1 hip-
pocampal synapse (Roberts et al., 2004a), suggesting that 5-
HT7 receptors are necessary for LTP. LTP is induced by activa-
tion of NMDA receptors and 5-HT7 receptors were shown to
exert different short- and long-term effects on NMDA-mediated
currents in hippocampal neurons. In particular, acute activa-
tion of 5-HT7 receptors enhanced the amplitude of NMDA-
mediated currents, whereas a long-term activation of 5-HT7
receptors reduced the cell membrane expression of NMDA
receptors through an indirect mechanism involving platelet-
derived growth factor (PDGF), an endogenous neurotrophin
that protects against NMDA-induced excitotoxicity (Vasefi et al.,
2013). This dual action of 5-HT7 receptors, namely a short-term
enhancement and a long-term inhibition of NMDA receptors,
might also explain different 5-HT7 receptor-mediated effects
on LTP.
Another form of long-term depression, mGluR-LTD, is
induced by activation of group I mGluRs and is mainly
expressed through removal of AMPA receptors from synap-
tic membrane surface by endocytosis (Luscher and Huber,
2010). We have shown that 5-HT7 receptor activation prevented
mGluR-induced endocytosis of AMPA receptors and reversed
mGluR-LTD in the CA3-CA1 synapse in mouse hippocam-
pal slices (Costa et al., 2012a). Interestingly, we found that
5-HT7 receptor activation reversed mGluR-mediated endocy-
tosis of AMPA receptors and mGluR-LTD also in Fmr1 KO
mice, a mouse model of Fragile X Syndrome, the most com-
mon form of inherited intellectual disability associated with
epilepsy and autism. Our result that 5-HT7 receptor acti-
vation can correct abnormal mGluR-mediated synaptic plas-
ticity in the mouse model of Fragile X Syndrome might
suggest new strategies for the therapy of this disorder (see
below).
PHYSIOLOGICAL FUNCTIONS REGULATED BY 5-HT7
RECEPTORS
5-HT7 receptors control several body functions including
the sleep-wake cycle, body temperature and nociception, and
strongly influence mood and learning, two higher brain func-
tions that are strictly related (Table 1). Most of the func-
tions regulated by 5-HT7 receptors have been studied using the
5-HT7 receptor knock-out (5-HT7 KO) mice that were gener-
ated and characterized by the research group of Dr. Hedlund
(Roberts et al., 2004a; Sarkisyan and Hedlund, 2009) and
later in other laboratories (Guscott et al., 2005; Witkin et al.,
2007).
SLEEP/WAKE CYCLE
Consistent with their abundant expression in the hypothalamus
(see Section Localization, Structure and Pharmacological Profile),
5-HT7 receptors play an important role in the regulation of
circadian rhythm and sleep (Monti and Jantos, 2014). In the
SCN, which is the main regulator of circadian rhythm, 5-HT7
receptors are abundantly expressed (Belenky and Pickard, 2001)
and regulate glutamatergic input from the retina (Smith et al.,
2001) and serotonergic input from raphe nuclei (Glass et al.,
2003).
The role of 5-HT7 receptors in sleep has emerged from studies
using both pharmacological and genetic approaches. 5-HT7 KO
mice displayed a reduced duration of REM sleep, whereas time
spent during wake or non-REM sleep was not different from wild-
type mice (Hedlund et al., 2005). Consistently, in vivo admin-
istration of a 5-HT7 receptor antagonist to wild-type animals
reduced the duration of REM sleep (Hagan et al., 2000; Thomas
et al., 2003; Bonaventure et al., 2007; Monti et al., 2012). However,
in contradiction with these results, systemic administration of
a 5-HT7 receptor agonist also enhanced the wake period and
reduced the duration of REM sleep (Monti et al., 2008, 2014),
together with inducing a phase-shift in the sleep-wake cycle
(Adriani et al., 2012). As a possible explanation, it has been
proposes that 5-HT7 receptors do not behave according to the
classical model of two-state on-off (activation/blockade) ligand-
receptor interaction (Monti and Jantos, 2014). In addition, 5-HT7
receptors differently modulate distinct brain areas (dorsal raphe,
locus coeruleus, basal forebrain) involved in sleep control (Monti
et al., 2012; Monti and Jantos, 2014) and their precise role in each
area should be further investigated.
BODY TEMPERATURE
5-HT7 receptors exert a well-established role in thermoregulation
(for extensive review on this topic, see Hedlund and Sutcliffe,
2004; Matthys et al., 2011). Administration of 5-HT7 receptor
agonists induced hypothermia in wild type guinea pigs and mice
(Hagan et al., 2000; Guscott et al., 2003; Hedlund et al., 2003,
2010) but not in 5-HT7 KO mice (Guscott et al., 2003; Hedlund
et al., 2003).
Two other 5-HT receptors are involved on thermoregula-
tion, namely 5-HT1A and 5-HT3 receptors, both also inducing
hypothermic effects (Hedlund et al., 2004; Naumenko et al.,
2011). It has been proposed that 5-HT7 receptors, possessing the
highest affinity for 5-HT, are activated by low doses of 5-HT
and are responsible for the fine-tuning of body temperature.
On the other hand, higher agonist concentrations activate 5-
HT1A receptors, which might play a role as a defense against
hyperthermia (Hedlund et al., 2004).
NOCICEPTION
Immunohistochemical studies provide evidence for localization
of 5-HT7 receptors in the superficial laminae of the dorsal horn
and in small and medium sized dorsal root ganglion cells, which
is consistent with a role of 5-HT7 receptors in nociception (Doly
et al., 2005).
The role of 5-HT7 receptors in the control of pain trans-
mission is multifaceted and has been described in details
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in recent reviews (Matthys et al., 2011; Viguier et al.,
2013). Overall, 5-HT7 receptor agonists induce pro-nociceptive
effects on peripheral 5-HT7 receptors and antinociceptive
effects on central 5-HT7 receptors (Yanarates et al., 2010;
Viguier et al., 2012), with a different outcome depend-
ing on preexisting conditions (health vs. neuropathic pain;
Viguier et al., 2013).
LEARNING AND MEMORY
In the last decade, an important role of 5-HT7 receptors on
learning and memory has emerged (Roberts and Hedlund, 2012;
Meneses, 2013). As pointed out in the previous paragraphs, 5-
HT7 receptors are expressed at high levels in the hippocampus,
one of the brain regions most crucially involved in learning,
and modulate hippocampal synaptic transmission and plasticity.
Behavioral studies performed on mice lacking 5-HT7 receptors
(Roberts et al., 2004a; Sarkisyan and Hedlund, 2009) and on wild-
type animals (Manuel-Apolinar and Meneses, 2004; Perez-Garcia
and Meneses, 2005; Eriksson et al., 2008, 2012) show that 5-HT7
receptor activation exerts a pro-cognitive action on different types
of memory.
5-HT7 KO mice showed no memory impairment in operant
food conditioning tests (involving a hippocampus-independent
type of memory) and Barnes maze (involving hippocampus-
dependent spatial learning) but displayed a memory deficit
in the fear conditioning test, which involves hippocampus-
dependent contextual learning with emotional aspects. These
results indicate that the lack of 5-HT7 receptors did not affect
hippocampus-independent memory and among different types of
hippocampus-dependent learning, only one with a strong emo-
tional component (fear conditioning) was selectively impaired in
5-HT7 KO mice. The specific contextual learning impairment of
5-HT7 KO mice was accompanied by a decrease of LTP in the CA1
region of the hippocampus (Roberts et al., 2004a).
Further studies from the same laboratory indicated that 5-
HT7 KO mice displayed normal recognition of novel objects
(Sarkisyan and Hedlund, 2009), a type of visual episodic memory
that depends on brain cortex and is believed to correspond to
human declarative episodic memory. 5-HT7 KO mice instead
showed a selective impairment in the recognition of a novel loca-
tion, particularly in allocentric spatial memory (a hippocampus-
dependent type of memory concerning the location of objects
independent from the observer), without any defect in egocen-
tric memory (a striatum-dependent type of memory concern-
ing the position of objects with respect to the observer). The
same result was observed in wild-type mice following pharma-
cological blockade of 5-HT7 receptors (Sarkisyan and Hedlund,
2009).
Behavioral studies on wild-type animals confirmed that acti-
vation of 5-HT7 receptors exerts a pro-cognitive effect on
hippocampus-dependent contextual learning and revealed that
other types of memory are also modulated by 5-HT7 receptors.
In mice submitted to the passive avoidance test (involving contex-
tual learning), in vivo activation of 5-HT7 receptors was able to
exert pro-cognitive effects and counteract a learning impairment
induced by 5-HT1A receptor activation (Eriksson et al., 2008,
2012).
5-HT7 receptor stimulation enhanced memory formation
in adult rats trained to a learning task involving both
conditioning (Pavlonian) and instrumental learning modes:
in this experimental protocol, a food reward was delivered
with a short delay following a light signal (conditioned learn-
ing) but was delivered immediately if the rat pressed a
lever (instrumental learning). When the 5-HT7 receptor ago-
nist AS-19 was injected subcutaneously to animals immedi-
ately after training, the latency of responses was reduced,
indicating enhanced memory performance. AS-19 administra-
tion was also able to reverse a memory impairment induced
by scopolamine (an anticholinergic agent) or dizocilpine (an
NMDA antagonist), suggesting that 5-HT7 receptor activation
might exert a pro-cognitive effect by modulating choliner-
gic and glutamatergic transmission (Perez-Garcia and Meneses,
2005).
Concerning hippocampus-independent memory, different
from results on 5-HT7 KO mice (Sarkisyan and Hedlund, 2009),
in wild-type mice novel object recognition was enhanced by
administration of the 5-HT7 receptor agonist 5-CT and impaired
by administration of the 5-HT7 receptor antagonist SB-269970
(Freret et al., 2014), consistent with previous data showing that
administration of SB-269970 impaired novel object recognition
in wild-type rats (Ballaz et al., 2007a). These data show that
5-HT7 receptor activation exert a pro-cognitive effect also on
cortex-dependent memory corresponding to human episodic
memory.
To summarize, studies on wild-type animals using 5-HT7
receptor agonists and antagonists have shown that 5-HT7 receptor
activation enhances many different types of memory, including
some (operant conditioning, novel object recognition) that were
not impaired in 5-HT7 KO mice.
5-HT7 receptor-mediated pro-cognitive effects were observed
in behavioral tests performed on adult animals, reinforcing the
conclusion that 5-HT7 receptors are functional in the adult hip-
pocampus and exert life-long effects on learning and memory.
In one study, blockade rather than activation of 5-HT7 recep-
tors exerted a pro-cognitive effect: in vivo administration of
the 5-HT7 receptor antagonist SB-269970 to rats submitted to
the radial arm maze enhanced long-term reference memory
without affecting short-term working memory (Gasbarri et al.,
2008).
Heterogeneous results are not surprising considering that dif-
ferent models have been used (either rats or mice; wild-type or
5-HT7 KO animals) and different types of memory were tested,
involving different brain areas and distinct circuits. Furthermore,
considering that learning and memory are strictly related to
stress, 5-HT7 receptor-mediated effects on learning might also
be influenced by 5-HT7 receptor-mediated effects on mood (see
below).
INVOLVEMENT OF 5-HT7 RECEPTORS IN PATHOLOGY
MOOD DISORDERS
Since the first pharmacological characterization of 5-HT7 recep-
tors, it was evident that several antipsychotics and antidepressants
bind these receptors with high affinity (Monsma et al., 1993; Roth
et al., 1994). In line with these early results, several studies have
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later shown that 5-HT7 receptors play a role in mood regulation
and thus are potential targets for the therapy of anxiety and
depression (Hedlund, 2009; Sarkisyan et al., 2010).
Mice lacking 5-HT7 receptors displayed reduced levels of
depression when submitted to forced swimming and tail suspen-
sion tests (Guscott et al., 2005; Hedlund et al., 2005). Consistently,
pharmacological blockade of 5-HT7 receptors exerted antidepres-
sant effects in wild-type mice and rats submitted to the same
stress protocols (Hedlund et al., 2005; Wesolowska et al., 2006a;
Mnie-Filali et al., 2011). In addition, 5-HT7 receptor blockade
was found to potentiate the effect of other antidepressant drugs:
synergistic antidepressant effects were observed when a low and
ineffective dose of SB-269970 was administered in combination
with a low and ineffective dose of citalopram, a selective serotonin
reuptake inhibitor (SSRI; Sarkisyan et al., 2010). In the same
study, a synergistic interaction, although to a lesser extent, was
also observed between SB-269970 and reuptake inhibitors of
norepinephrine (but not dopamine).
With respect to anxiety, 5-HT7 KO mice did not show any
alteration in anxiety-related behavior, evaluated by light-dark
transfer test (Roberts et al., 2004a) and elevated plus maze
(Guscott et al., 2005). On the other side, in wild-type rodents
tested in different anxiety protocols (Vogel conflict drinking test;
elevated plus maze; four-plate test; open field), administration
of the 5-HT7 receptor antagonist SB-269970 induced anxiolytic
effects (Wesolowska et al., 2006a,b).
Interestingly, anxiolytic and antidepressant effects were
observed also when SB-269970 was administered by local
intra-hippocampal injection, indicating the involvement of 5-
HT7 receptors located in the hippocampus (Wesolowska et al.,
2006a).
It was recently found that second-generation antipsychotic
drugs, named atypical antipsychotics, also behave as antago-
nists of 5-HT7 receptors. Among these substances, the D2/D3
receptor antagonist amisulpride is a high-affinity competitive
antagonist of 5-HT7 receptors. Interestingly, the antidepressant
effect of amisulpride was absent in 5-HT7 KO mice, indicating
that it was mediated exclusively by inhibition of 5-HT7 receptors
(Abbas et al., 2009). Lurasidone, another atypical antipsychotic
behaving as an antagonist at dopamine D2, 5-HT2, and 5-HT7
receptors (Ishibashi et al., 2010), was shown to exert significant
antidepressant effects in patients with bipolar 1 disorder (Woo
et al., 2013). Another atypical antipsychotic is vortioxetine, also
named Lu AA21004, a multimodal compound that behaves as
an antagonist at 5-HT3 and 5-HT7 receptors, a partial agonist
at 5-HT1B, a full agonist at 5-HT1A receptors and an inhibitor
of the serotonin transporter (Guilloux et al., 2013). Vortioxetine
proved effective as antidepressant in several clinical studies and
was recently approved by the U.S. Food and Drug Administration
(FDA) for the treatment of major depressive disorder (Citrome,
2014), confirming that an enhancement of serotonergic transmis-
sion associated with 5-HT7 receptor antagonism exerts synergistic
antidepressant effects.
These data together indicate that 5-HT7 receptors regulate
the balance between anxiety and depression. Mood regulation
has crucial consequences on cognition, as stress can improve
or impair learning depending on the duration and intensity of
stressful conditions. Acute stress enhances learning, particularly
when experienced in the same context of learning acquisition
(Joëls et al., 2006; Bangasser and Shors, 2010). As underlined
above, 5-HT7 receptor activation improves fear-related learning,
in which an acute stressor is presented during the paradigms of
fear conditioning and passive avoidance (Roberts et al., 2004a;
Eriksson et al., 2008). Therefore, an enhancement of anxiety levels
by 5-HT7 receptor activation during a stress condition might
contribute to 5-HT7 receptor-mediated improvement of stress-
related learning.
EPILEPSY
In view of the depolarizing effects exerted by 5-HT7 receptors
(see above), their activation is likely to enhance seizure sensitivity.
In line with this, a pharmacological study using different mixed
antagonists suggested that blockade of 5-HT7 receptors may pro-
tect against audiogenic seizures in DBA/2J mice (Bourson et al.,
1997). Pharmacological blockade using selective 5-HT7 receptor
antagonists decreased cortical epileptic activity in a rat genetic
model of absence epilepsy (Graf et al., 2004) and in a pilocarpine-
induced rat model of temporal lobe epilepsy (Yang et al., 2012).
In contrast, 5-HT7 receptor activation was instead suggested
to exert anticonvulsant effects in other experimental models of
epilepsy. Systemic administration of the 5-HT7 receptor agonist
5-CT reduced picrotoxin-induced seizures in mice, an effect
abolished by a selective 5-HT7 receptor antagonist (Pericic and
Svob Strac, 2007). Consistently, mice lacking 5-HT7 receptors dis-
play enhanced sensitivity to electrically and chemically-induced
seizures (Witkin et al., 2007).
Thus, 5-HT7 receptor-mediated effects on epilepsy are hetero-
geneous and apparently controversial, probably due to differences
in the models used. Systemic administration of 5-HT7 receptor
ligands exerts a complex modulation of the brain serotonin sys-
tem because, besides directly acting on 5-HT7 receptors on target
cells, they also modulate the activity of GABAergic interneurons.
As pointed out in the previous paragraphs, in raphe nuclei 5-HT7
receptor activation inhibits GABAergic interneurons targeting
serotonergic neurons and subsequently enhance 5-HT release in
other brain areas. In the hippocampus, GABAergic interneurons
are instead stimulated by 5-HT7 receptor activation. Therefore,
the understanding of systemic effects exerted by 5-HT7 receptor
ligands is complicated by 5-HT7 receptor-mediated modulation
of GABAergic interneurons in distinct brain areas.
Concerning systemic administration of 5-HT7 receptor ago-
nists, it should also be considered that 5-HT7 receptors undergo
desensitization following prolonged activation (Shimizu et al.,
1998). Desensitization of 5-HT7 receptors was also observed after
antagonist treatment (Tokarski et al., 2012b). Thus, systemic
treatments of animals should be carefully designed to mini-
mize 5-HT7 receptor desensitization; in this respect, a preferen-
tial use of agonists with a short half-life, such as LP-211 and
related compounds (Hedlund et al., 2010) might be considered
preferentially.
THE SEROTONIN HYPOTHESIS OF AUTISM
A large body of evidence has led to the serotonin hypothesis
of autism, which points out a deficiency in the brain serotonin
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system as a causal mechanism in ASD (Whitaker-Azmitia, 2005;
Harrington et al., 2013). Early experimental data (Schain and
Freedman, 1961), later confirmed by many research groups
(Anderson et al., 1990; Piven et al., 1991; McBride et al., 1998;
Mulder et al., 2004), have documented an increase of serotonin
levels in blood platelets (hyperserotonemia) in one third of
autistic patients. Conversely, a decreased uptake of tryptophan
(the precursor of 5-HT) and a reduced 5-HT synthesis were
detected in the brain of autistic children by positron emission
tomography (PET) using the radioligand tracer alpha-methyl-
tryptophan (Chugani et al., 1997, 1999; Chandana et al., 2005).
These studies have evidenced that global brain 5-HT synthesis
was reduced in autistic patients in an age-dependent manner,
with local differences in cortical regions. The localization of 5-
HT defect was related to the severity of language problems, as
children with the most severe language delay displayed the lowest
amount of tryptophan uptake in the left cortex. Overall, in very
young autistic children (2–5 years old) the rate of 5-HT synthesis
in frontal, temporal and parietal cortex was significantly lower
with respect to healthy children of the same age and was grad-
ually increased only later in development (5–14 years old). The
authors suggested that a high brain serotonin synthesis normally
occurring during early childhood is disrupted in autism (Chugani
et al., 1999).
A lack of 5-HT during early stages of development is likely
to disrupt the wiring architecture of the brain. Consistently,
post mortem observation of brains from young autistic patients
showed an abnormal morphology of serotonergic fibers directed
to the amygdala and temporal cortex and an increased density
of the serotonin transporter (named either 5-HTT or SERT) on
these fibers (Azmitia et al., 2011).
The 5-HTT is responsible for 5-HT uptake in CNS sero-
tonergic nerve terminals, reducing the amount of 5-HT in the
synaptic cleft. The 5-HTT is also located on blood platelets and
up-regulation of 5-HTT activity participates to their increased
uptake of serotonin, leading to hyperserotonemia (Marazziti et al.,
2000). The gene coding for the 5-HTT, named SLC6A4, exists in
various alleles related to different degrees of 5-HTT expression
and/or activity. Polymorphism of the SLC6A4 gene has been
correlated with autism, although results from different groups are
heterogeneous with respect to the polymorphic sites involved and
the type of allele associated with autism (Devlin et al., 2005; Cho
et al., 2007; Coutinho et al., 2007; Wassink et al., 2007; Cross et al.,
2008); however, others did not find any significant association
(Ramoz et al., 2006). A SLC6A4 variant coding for an overactive
form of 5-HTT has been identified in families of autistic patients
(Sutcliffe et al., 2005). Mutant mice expressing this high function-
ing 5-HTT variant show hyperserotonemia, hypersensitivity of 5-
HT receptors (as a result of reduced serotonergic transmission)
and autistic behavior (Veenstra-VanderWeele et al., 2012).
Alterations in brain 5-HT receptor density were found in
autistic patients. A reduction of 5-HT2A binding sites in the
cingulate, frontal, and temporal cortex was detected in adults
with Asperger syndrome by single photon emission computed
tomography (SPECT; Murphy et al., 2006), although a later PET
study found contrasting results (Girgis et al., 2011). A reduced
density of 5-HT1A and 5-HT2 receptors in posterior cingulate
cortex and fusiform cortex, brain regions involved in social and
emotional behaviors, was observed in post-mortem brain tissue
from young adults diagnosed with autism other than Asperger
syndrome (Oblak et al., 2013).
To summarize, a large number of clinical studies indicate
abnormal synthesis and increased uptake of 5-HT, morphological
alteration of serotonergic fibers and reduced expression of 5-HT
receptors in the brain of ASD patients. Consistently, neonatal
mice depleted of forebrain serotonin by neurotoxin injection
at birth (Boylan et al., 2007) and mice genetically depleted of
serotonin (Kane et al., 2012) show a delay in development and
typical autistic features, and have been proposed as animal models
of ASD. Other animal models of ASD were instead generated by
manipulations inducing pre-natal hyperserotonemia and postna-
tal loss of brain 5-HT, such as fetal exposure to sodium valproate
(Dufour-Rainfray et al., 2011) or to 5-methoxytryptamine (5-
MT), a non-selective agonist of all metabotropic 5-HT receptor
types (McNamara et al., 2008). According to a developmental
theory of autism, prenatal hyperserotonemia causes increased 5-
HT levels in the fetal brain, as the immature blood-brain barrier is
permeable to 5-HT; this in turn would cause a loss of serotoner-
gic fibers as a negative feedback mechanism (Whitaker-Azmitia,
2005; McNamara et al., 2008). Thus, prenatal hyperserotonemia
would ultimately reduce the function of the brain serotonin
system and lead to consequences similar to post-natal serotonin
depletion.
Animal studies have confirmed the involvement of 5-HT in
ASD and provided some indication about the 5-HT-dependent
mechanisms disrupted in ASD. In 5-HTT knockout animals,
the lack of 5-HTT during early development altered the con-
nectivity between raphe nuclei and prefrontal cortex (Witteveen
et al., 2013), as well as cortical cell density and layer thickness
(Altamura et al., 2007; Witteveen et al., 2013). Also neona-
tal 5-HT depletion in mouse forebrain caused a disruption in
neocortical architecture, namely an increase of cortical thick-
ness (Boylan et al., 2007) resembling the increased cortical
volume observed in autistic patients (Carper and Courchesne,
2005).
In a hyperserotonemia rat model of autism, a reduced num-
ber of oxytocin neurons was detected in the hypothalamic
paraventricular nucleus (PVN; McNamara et al., 2008). The
PVN projects oxytocin-containing fibers to the NAc, where pre-
synaptic oxytocin receptors stimulate 5-HT release from sero-
tonergic nerve terminals arising from dorsal raphe. Thus, a
reduced activity of this pathway might have important impli-
cation in the pathophysiology of autistic behavior. As a matter
of fact, a recent study shows that 5-HT and oxytocin cooperate
in the NAc and their combined activity is crucially involved in
social reward, a mechanism disrupted in autism (Dölen et al.,
2013).
5-HT7 RECEPTORS AS A POSSIBLE NOVEL THERAPEUTIC
TARGET IN AUTISM SPECTRUM DISORDERS
Little is known about a possible malfunction of 5-HT7 recep-
tors in ASD. A single base polymorphism was detected in the
gene coding for the 5-HT7 receptor, giving rise to two differ-
ent alleles; however, analysis of transmission disequilibrium in
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autistic patients did not evidence any correlation of either allele
to autism (Lassig et al., 1999). The expression level of 5-HT7
receptors in the brain of autistic patients has not been specifically
investigated and no information is presently available about the
functional properties of 5-HT7 receptors in animal models of
autism.
Although a dysfunction of 5-HT7 receptors has not been
causally linked to ASD, we propose that 5-HT7 receptor ligands
might be considered as valuable pharmacological tools in ASD.
This suggestion is mainly based on our findings but is also
supported by other studies addressing the role of 5-HT7 recep-
tors in behavioral flexibility and repetitive behavior, as discussed
below. We have shown that 5-HT7 receptor activation reverses
mGluR-LTD in Fmr1KO mice (Costa et al., 2012a), a model
of Fragile X Syndrome also considered as an animal model of
autism (Bernardet and Crusio, 2006; Pietropaolo et al., 2011).
This result might open new perspectives for therapy if pharmaco-
logical activation of 5-HT7 receptors, besides correcting the most
prominent synaptic defect in the mouse model of FXS, is also able
to rescue the symptoms of FXS such as learning deficits, epilepsy
and autistic behavior.
A typical feature of ASD is a reduced behavioral flexibility, i.e.,
a reduced ability to replace a previously acquired rule with a new
one, in adaptation to a new environmental context. Behavioral
flexibility depends on brain circuits involving pre-frontal cortex
(Floresco et al., 2009; Wolfensteller and Ruge, 2012; Logue and
Gould, 2014) and can be evaluated in animals as well as in humans
using an attentional set-shifting task (Birrell and Brown, 2000;
Colacicco et al., 2002). In this test, rodents are trained to dis-
criminate between different stimuli (odor, surface texture, digging
medium) as a cue to obtain a reward. After a training period, the
rules are changed and animals must learn that a previously rele-
vant cue has become irrelevant and vice-versa. Using attentional
set-shifting protocols, recent studies have shown an involvement
of 5-HT7 receptors in behavioral flexibility, especially in con-
ditions of stress (Nikiforuk, 2012; Nikiforuk and Popik, 2013).
Rats exposed to restraint stress showed reduced behavioral flex-
ibility; administration of amisulpride, an atypical antipsychotic
drug and a 5-HT7 receptor antagonist, reversed the restraint-
induced cognitive inflexibility and also improved attention in
unstressed animals. Administration of the 5-HT7 receptor agonist
AS-19 abolished the pro-cognitive effect of amisulpride. The
same authors have shown that behavioral inflexibility induced
by another protocol (ketamine administration) was reduced by
amisulpride and by the 5-HT7 receptor antagonist SB-269970
(Nikiforuk et al., 2013). These results suggest that a lack of behav-
ioral flexibility is associated with increased activation of 5-HT7
receptors. In this respect, antagonists rather than agonist of 5-HT7
receptors might be beneficial to correct the reduced behavioral
flexibility observed in ASD. However, further studies are necessary
to test the effects of 5-HT7 receptor agonists and antagonist
on cognitive flexibility in different pathological conditions. In
particular, it would be useful to study the relation between altered
synaptic plasticity and behavioral flexibility in different models
of intellectual disability and autism. For example, the Fmr1 KO
mouse model of Fragile X Syndrome exhibit an abnormally
enhanced mGluR-LTD (Huber et al., 2002) and show autistic
features and reduced behavioral flexibility (Casten et al., 2011).
On the other side, mGluR-LTD is abnormally reduced in other
mouse models of syndromic and non syndromic forms of autism,
which also show reduced behavioral flexibility. We are currently
studying if systemic administration of a 5-HT7 receptor agonist
can rescue learning deficits and altered behavior in Fmr1 KO
mice. Our hypothesis is that 5-HT7 receptor activation, although
reducing behavioral flexibility in wild-type animals (Nikiforuk,
2012; Nikiforuk and Popik, 2013), might restore behavior and
thus be beneficial in Fragile X syndrome, a condition in which
mGluR-LTD is exaggerated.
Repetitive and stereotypic behavior is considered a core symp-
tom of ASD. A behavioral study has shown that the stereotypical
behavior of marble burying, an experimental protocol used to
evaluate anxiety and obsessive-compulsive behavior, was reduced
in 5-HT7 KO mice and in wild-type mice following pharma-
cological blockade of 5-HT7 receptors (Hedlund and Sutcliffe,
2007). The authors suggest that this result might also be due
to the anxiolytic effect of 5-HT7 receptor blockade (Hedlund,
2009).
Co-morbid symptoms of ASD, observed only in a fraction
of patients, include sleep disorders, anxiety, depression, epilepsy,
attention deficit and hyperactivity disorder (Spooren et al., 2012).
As pointed out in the previous paragraphs, 5-HT7 receptors
are crucially involved in the regulation of the sleep/wake cycle,
exert either pro- or anti-convulsant effects in different models of
epilepsy and play an important role in mood control (reviewed
by Bagdy et al., 2007; Matthys et al., 2011). Since 5-HT7 receptor
inactivation or blockade exert anxiolytic effects (see above), 5-
HT7 receptor activation is likely to enhance the level of anxiety,
thus might be expected to reduce hyperactivity. In line with this
hypothesis, in highly active rats showing explorative behavior and
low levels of anxiety, the expression level of 5-HT7 receptors in the
thalamus and in the hippocampus was significantly lower than in
low-activity rats (Ballaz et al., 2007b). Accordingly, another study
shows that microinjections of the 5-HT7 receptor agonist AS-19
into the NAc decreased ambulatory activity in the rat (Clissold
et al., 2013).
Other publications instead show that systemic administration
of the 5-HT7 receptor agonist LP-211 enhanced locomotion in
wild-type mice (Adriani et al., 2012) and exerted anxiolytic
effects, enhancing the exploratory attitude, in a rat model of
hyperactivity and attention deficit (Ruocco et al., 2013). There-
fore, it would be interesting to further investigate the role of 5-
HT7 receptors on different types of anxiety-related behaviors.
CONCLUDING REMARKS
Central 5-HT7 receptors modulate neuronal excitability and
synaptic function and are important physiological modulators of
learning and mood. Based on these properties, 5-HT7 receptors
have been proposed as a pharmacological target in cognitive
impairment, depression and epilepsy.
Core and co-morbid symptoms of ASD involve a disruption
of several functions, some of which are physiologically regulated
by 5-HT7 receptors. In light of this, it would be interesting
to investigate the role of 5-HT7 receptors on different features
disrupted in ASD. Cognitive functions are likely to be enhanced by
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5-HT7 receptor agonists; on the other side, behavioral flexibility,
hyperactivity and epilepsy might benefit from blockade of 5-HT7
receptors. In many cases, predictions of a possible outcome by
pharmacological manipulation of 5-HT7 receptors are compli-
cated by heterogeneous data present in literature and a direct
investigation would be necessary.
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